Vizamyl ( DrugBank: - )

3 diseases

ID	Disease name (Link within this page)	Number of trials
5	Progressive supranuclear palsy	1
7	Corticobasal degeneration	1
127	Frontotemporal lobar degeneration	1

5. Progressive supranuclear palsy

Clinical trials : 89 / Drugs : 107 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-000094-36-SE (EUCTR)	31/03/2017	30/01/2017	The BioFINDER 2 study - improved diagnostics and increased understanding of the underlying mechanism ...	The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of c ...	Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimers disease, p ...	Product Name: 18F-RO6958948 Trade Name: Vizamyl (flutemetamol(F-18)) Product Name: Vizamyl	Skåne University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Sweden

Clinical trials : 16 / Drugs : 28 - (DrugBank : 13) / Drug target genes : 9 - Drug target pathways : 38

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-000094-36-SE (EUCTR)	31/03/2017	30/01/2017	The BioFINDER 2 study - improved diagnostics and increased understanding of the underlying mechanism ...	The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of c ...	Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimers disease, p ...	Product Name: 18F-RO6958948 Trade Name: Vizamyl (flutemetamol(F-18)) Product Name: Vizamyl	Skåne University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Sweden

Clinical trials : 90 / Drugs : 87 - (DrugBank : 30) / Drug target genes : 39 - Drug target pathways : 88

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-000094-36-SE (EUCTR)	31/03/2017	30/01/2017	The BioFINDER 2 study - improved diagnostics and increased understanding of the underlying mechanism ...	The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of c ...	Neurodegenerative disorders with Tau-pathology; including, but not limited to, Alzheimers disease, p ...	Product Name: 18F-RO6958948 Trade Name: Vizamyl (flutemetamol(F-18)) Product Name: Vizamyl	Skåne University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 2	Sweden